Grantham, Mayo, Van Otterloo & Co (GMO)’s CR Bard Inc. BCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-196,200
Closed -$62.9M 667
2017
Q3
$62.9M Sell
196,200
-173,800
-47% -$55.6M 0.37% 64
2017
Q2
$117M Buy
370,000
+364,073
+6,143% +$108M 0.65% 42
2017
Q1
$1.47M Sell
5,927
-89,940
-94% -$21.7M 0.01% 339
2016
Q4
$21.5M Sell
95,867
-2,183
-2% -$474K 0.12% 139
2016
Q3
$22M Buy
+98,050
New +$22.1M 0.1% 157
2016
Q2
Sell
-69,375
Closed -$14.1M 666
2016
Q1
$14.1M Sell
69,375
-34,700
-33% -$6.55M 0.05% 210
2015
Q4
$19.7M Sell
104,075
-22,395
-18% -$4.19M 0.07% 156
2015
Q3
$23.6M Sell
126,470
-68,151
-35% -$12.9M 0.08% 144
2015
Q2
$33.2M Sell
194,621
-31,300
-14% -$5.35M 0.11% 119
2015
Q1
$37.8M Sell
225,921
-33,443
-13% -$5.73M 0.11% 110
2014
Q4
$43.2M Buy
259,364
+47,670
+23% +$7.71M 0.12% 101
2014
Q3
$30.2M Sell
211,694
-700
-0.3% -$103K 0.08% 117
2014
Q2
$30.4M Buy
212,394
+13,300
+7% +$1.9M 0.08% 115
2014
Q1
$29.5M Buy
199,094
+93,581
+89% +$13M 0.08% 123
2013
Q4
$14.1M Sell
105,513
-10,985
-9% -$1.45M 0.03% 176
2013
Q3
$13.4M Sell
116,498
-15,247
-12% -$1.75M 0.04% 177
2013
Q2
$14.3M Buy
+131,745
New +$13.7M 0.04% 165

Other funds holding BCR

Grantham, Mayo, Van Otterloo & Co (GMO)'s BCR Position: Q4 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CR Bard Inc. (BCR) in Q4 2017, closing a stake of 196,200 shares — an estimated $62.9M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BCR in Q2 2013 and held it in 17 quarters. The position peaked at $117M in Q2 2017. 111 funds tracked by Wall St. Rank hold BCR as of Q4 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CR Bard Inc. position as of Q4 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 196,200 CR Bard Inc. shares in Q4 2017, an estimated $62.9M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CR Bard Inc. in Q2 2013 and held it in 17 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CR Bard Inc. position peaked at $117M in Q2 2017.
  • 111 funds tracked by Wall St. Rank held CR Bard Inc. as of Q4 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2017, filed 14 Feb 2018.